Viewing Study NCT01057251

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-02-10 @ 11:27 AM
Study NCT ID: NCT01057251
Status: COMPLETED
Last Update Posted: 2012-01-11
First Post: 2010-01-26
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Nebivolol in Patients With Systolic Stage 2 Hypertension
Sponsor: Forest Laboratories
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Nebivolol View
None Bystolic TM View
None Hypertension View
None Stage 2 Hypertension View